buy medicine online indiamedicine onlineloading...

    Telmisartan + Metoprolol Succinate

    Information about Telmisartan + Metoprolol Succinate

    Telmisartan + metoprolol succinate uses

    Telmisartan+Metoprolol Succinate is used in the treatment of Hypertension (high blood pressure).

    How telmisartan + metoprolol succinate works

    This is a combination of two blood-pressure lowering medicines: Telmisartan and Metoprolol Succinate. Telmisartan is an angiotensin receptor blocker (ARB). It works by blocking the chemical angiotensin, thereby relaxing blood vessels. Metoprolol Succinate is a beta blocker which works specifically on the heart to reduce heart rate and lower blood pressure. Together they allow the blood to flow more smoothly and the heart to pump more efficiently.

    Common side effects of telmisartan + metoprolol succinate

    Headache, Weakness, Dizziness, Cold extremities, Slow heart rate, Increased potassium level in blood, Numbness of extremity, Decreased blood pressure
    Content Details
    Written By
    Dr. Radhika Dua
    MDS, BDS
    Reviewed By
    Dr. Shilpa Garcha
    MD (Pharmacology), MBBS
    Last updated on:
    11 Jun 2019 | 05:49 PM (IST)
    Want to know more?
    Read Our Editorial Policy

    Available Medicine for Telmisartan + Metoprolol Succinate

    • ₹155 to ₹188
      Sun Pharmaceutical Industries Ltd
      2 variant(s)
    • ₹131 to ₹144
      USV Ltd
      2 variant(s)
    • ₹142 to ₹186
      Torrent Pharmaceuticals Ltd
      2 variant(s)
    • ₹154 to ₹189
      Glenmark Pharmaceuticals Ltd
      2 variant(s)
    • ₹88 to ₹107
      Mankind Pharma Ltd
      2 variant(s)
    • ₹81 to ₹99
      Aristo Pharmaceuticals Pvt Ltd
      2 variant(s)
    • ₹105 to ₹145
      Emcure Pharmaceuticals Ltd
      2 variant(s)
    • ₹98 to ₹108
      Micro Labs Ltd
      3 variant(s)
    • ₹181 to ₹197
      Ajanta Pharma Ltd
      2 variant(s)
    • ₹129 to ₹158
      Medley Pharmaceuticals
      2 variant(s)

    Expert advice for Telmisartan + Metoprolol Succinate

    • You have been prescribed Telmisartan + Metoprolol Succinate for the treatment of high blood pressure.
    • Lowering blood pressure reduces chance of future heart attack & strokes.
    • It may cause dizziness. Get up slowly when rising from a sitting or lying position.
    • Do not stop taking the medication suddenly without talking to your doctor as it can cause sudden increase in your blood pressure.

    Frequently asked questions for Telmisartan + Metoprolol Succinate

    Telmisartan + Metoprolol Succinate

    Q. Can I feel dizzy after taking Telmisartan+Metoprolol Succinate?

    Yes, the use of Telmisartan+Metoprolol Succinate Succinate can make you feel dizzy. This may occur when you suddenly rise up from lying or sitting position. To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down.

    Q. What lifestyle changes should be made while using Telmisartan+Metoprolol Succinate?

    Making lifestyle changes can boost your health while taking Telmisartan+Metoprolol Succinate Succinate. Stop smoking, as smoking increases your risk of having heart attack and stroke. If you are overweight or obese, try to lose weight. You should maintain a healthy diet by including fruits and vegetables in your meals. Regular exercise can make your heart strong and reduce your risk of heart attack.

    Q. Can I stop taking Telmisartan+Metoprolol Succinate when I feel better?

    No, keep using Telmisartan+Metoprolol Succinate as advised by your doctor, even if you feel well. Stopping Telmisartan+Metoprolol Succinate suddenly may lead to serious complications such as heart attack and stroke.

    Q. Are there any special instructions regarding storage and disposal of this medicine?

    Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.

    Content on this page was last updated on 11 June, 2019, by Dr. Varun Gupta (MD Pharmacology)